Management of ovarian cancer: Referral to a multidisciplinary team matters

British Journal of Cancer

Volumn 70, Issue 2, 1994, Pages 363-370

  Junor, E J ^a   Hole, D J ^a   Gillis, C R ^a  

^a RUCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARBOPLATIN; CISPLATIN; PLATINUM DERIVATIVE;

ARTICLE; ASCITES; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; FEMALE; GYNECOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OUTPATIENT DEPARTMENT; OVARY CANCER; PATHOLOGY; PATIENT CARE; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; UNITED KINGDOM;

AGED; COMPARATIVE STUDY; FEMALE; HUMAN; MIDDLE AGE; OVARIAN NEOPLASMS; PATIENT CARE TEAM; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SCOTLAND; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0028124109     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1994.307     Document Type: Article

References (22)

1. ADVANCED OVARIAN CANCER TRIALISTS GROUP (1991). Chemotherapy in advanced ovarian cancer, an overview of randomised clinical trials. Br. Med. J., 303, 884-893.
2. BALVERT-LOCHT, H.R., COEBERGH, J.W.W., HOP, W.C.J., BROL-MANN, H.A.M., CROMMELIN, M., VAN WIJCK, D.J.A.M. & VERHAGEN-TEUUNGS, M.T.C.I.J. (1991). Improved prognosis of ovarian cancer in the Netherlands during the period 1975-85: a registry-based study. Gynecol. Oncol., 42, 3-8.
3. BLACK, R.J., SHARP, L. & KENDRICK, S.W. (1993). Trends in Cancer Survival in Scotland 1968-1990. Information and Statistics Division, Directorate of Information Services, National Health Service in Scotland: Edinburgh.
4. COX, D.R. (1970). The Analysis of Binary Data. Methuen: London.
5. COX, D.R. (1972). Regression models and life tables. J. R. Stat. Soc. (B), 34, 187-220.
6. DAVIS, S., WRIGHT, P.W., SCHULMAN, S.F., HILL, L.D., PINKHAM, R.D., JOHNSON, L.P, JONES, T.W., KELLOGG, H.B., RADKE, H.M., SIKKEMA, W.W., JOLLY, P.C. & HAMMAR S.P. (1985). Participants in prospective randomised clinical trials for resected non-small cell lung cancer have improved survival compared with non participants in such trials. Cancer, 56, 1710-1718.
7. GILUS, C.R, HOLE, DJ., STILL, R.M., DAVIS, J. & KAYE, S B. (1991). Medical audit, cancer registration, and survival in ovarian cancer. Lancet, 337, 611-612.
8. GRIFFITHS, C.T. (1975). Surgical resection of tumour bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst. Monogr., 42, 101-104.
9. HARDING, M.J., PAUL, J., GILLIS, C.R & KAYE, S.B. (1993). Management of malignant teratoma. Does referral to a specialist unit matter? Lancet, 341, 999-1002.
10. HOGBERG, T., CARSTENSEN, J. & SIMONSEN, E. (1993). Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer. Gynaecol. Oncol., 48, 38-49.
11. HOLE, D.J. & GILLIS, C.R (1993). Use of cancer registry data to evaluate the treatment of ovarian cancer on a hospital basis. Hlth Rep., 5, 117-119.
12. KARJALAINEN, S. (1990). Geographical variation in cancer patient survival in Finland: chance, confounding, or effect of treatment? J. Epidemiol. Community Health, 44, 210-214.
13. KARJALAINEN, S. & PALVA, I. (1989). Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland. Br. Med. J., 299, 1069-1072.
14. LENNOX, E.L., DRAPER, G.J. & SANDERS, B.M. (1975). Retinoblastoma: a study of natural history and prognosis of 268 cases. Br. Med. J., 3, 731-734.
15. MALKAISAN, G.D., DECKER, D.G. & WEBB, M.J. (1975). Histology of epithelial tumours of the ovary: clinical usefulness and prognostic signficance of histologic classification and grading. Semin. Oncol., 2, 191-201.
16. MANAGEMENT OF OVARIAN CANCER (1991). Current Clinical Practices, Report of a Working Group. Chairman: Professor J.S. Scott. Standing Subcommittee on Cancer of the Standing Medical Advisory Committee. Department of Health.
17. OMURA, G.A, BRADY, M.F., HOMESLEY, H.D., YORDAN, E., MAJOR F.J., BUCHSBAUM, H.J. & PARR, R.C. (1991). Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma. The Gynaecologic Oncology Group experience. J. Clin. Oncol., 9, 1138-1150.
18. RIES, L.A.G., HANKEY, B.F., MILLER B.A., HARTMAN, A.M. & EDWARDS, B.K. (1991). Cancer Statistics Review 1978-88. National Cancer Institute. NIH Publication No. 91-2789. NCI: Bethseda, MD.
19. STILLER, C.A. (1988). Centralisation of treatment and survival rates for cancer. &rch. Dis. Child., 63, 23-30.
20. STILLER, C.A. & DRAPER, G.J. (1989). Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch. Dis. Child., 64, 657-661.
21. VOEST, E.E., van HOUWELINGEN, J.C. & NEIJT, J.P. (1989). A metaanalysis of prognostic factors in advanced ovarian cancer with median survival and overall survival measured with log (relative risk) as main objectives. Eur. J. Cancer Clin. Oncol., 27, 711-720.
22. WHO (1976). International Classification of Diseases for Oncology. WHO: Geneva.